首页> 外文期刊>Robotics and Machine Learning >Critical Outcome Technologies Inc. Announces COTI-2 Scientific Results Accepted for Presentation at Influential Scientific Conference
【24h】

Critical Outcome Technologies Inc. Announces COTI-2 Scientific Results Accepted for Presentation at Influential Scientific Conference

机译:关键成果技术有限公司宣布在有影响力的科学会议上发表COTI-2科学成果

获取原文
获取原文并翻译 | 示例

摘要

Critical Outcome Technologies Inc. (COTI) (TSX VENTURE:COT) announced that a scientific abstractnabout its lead oncology compound, COTI-2, has been accepted for presentation at the upcomingnscientific conference, Discovery on Target: Emerging Targets for the Kinase Inhibitor Pipeline. Thenpresentation entitled COTI-2: A highly effective and selective modulator of Akt/Akt2 protein levels andnphospho-activation for the treatment of susceptible human cancers will be presented by Dr. WaynenDanter, COTI's CEO and CSO. This conference is being held November 2-4, 2011 in Boston, MA.
机译:关键成果技术有限公司(COTI)(TSX VENTURE:COT)宣布,有关其领先的肿瘤化合物COTI-2的科学摘要已被接受在即将举行的科学大会“目标发现:激酶抑制剂管线的新兴目标”上进行介绍。随后的演讲将由COTI首席执行官兼首席运营官WaynenDanter博士介绍,该演讲名为COTI-2:Akt / Akt2蛋白水平和n磷酸激活的高效选择性调节剂,用于治疗易感性人类癌症。该会议将于2011年11月2-4日在马萨诸塞州波士顿举行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号